Catalyst
Slingshot members are tracking this event:
FDA Grants Merrimack Fast Track Designation for Seribantumab (MM-121) in Non-small Cell Lung Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MACK |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 06, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Non-small Cell Lung Cancer, Mm-121, Seribantumab, Immunotherapy, Heregulin-positive Cancer Cells, Sherloc Trial
